CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 10 enrolled
Drug / intervention
Cosoptdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00379834
NCT00379834Phase 4Completed
CompareCT.gov

12-Month Stability of Diurnal IOP Control on Cosopt

West Virginia University·interventional·Posted Sep 25, 2006·Updated Feb 10, 2015

In Brief

A Phase 4 clinical trial evaluating Cosopt for Glaucoma. Completed, enrolled 10 participants.

Detailed Summary

To determine the stability of diurnal intraocular pressure in eyes with glaucoma treated with Cosopt

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 25, 2006
Enrollment StartSep 1, 2006
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 19.8 years ago

Interventions

Cosoptdrug

Cosopt twice daily in both eyes